Experimental mRNA therapy shrinks aggressive tumours in landmark cancer trial

A personalised mRNA vaccine combined with immunotherapy reduced tumour size by 60% in patients with advanced melanoma. Researchers say the approach could be adapted for lung and pancreatic cancers within two years.

4 hrs ago

Long Covid study finds lasting brain inflammation in patients even three years after infection

PET scans revealed persistent neuroinflammation in regions linked to memory and concentration. The findings could explain why many long Covid sufferers report ongoing cognitive difficulties.

5 hrs ago

Red Cross warns medicine supplies running critically low in besieged areas of southern Lebanon

Insulin, antibiotics, and surgical supplies are nearly exhausted in several field hospitals. Aid convoys have been unable to reach affected areas for over a week due to ongoing hostilities.

6 hrs ago

NHS waiting list drops below six million for first time in two years after reform push

The government's surgical hubs programme and expanded evening clinics have helped clear a backlog that peaked at 7.8 million in late 2024. But cancer treatment targets remain unmet.

8 hrs ago

First human trial of Alzheimer's nasal vaccine shows promising immune response

Participants who received the spray developed antibodies targeting amyloid plaques without serious side effects. A larger Phase 2 trial is expected to begin later this year.

10 hrs ago